Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.
- DOI
- 10.1136/rmdopen-2025-006549
- Published
- 2026 Mar 19
- Container
- RMD open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2025-006549,
title = {Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.},
author = {Calvo-Río V and Secada-Gómez C and Martín-Gutiérrez A and Retuerto-Guerrero M and Font J and Casafont-Solé I and Mayo-Juanatey A and Alegre Sancho JJ and Freites D and Hormigos C and Garrido Puñal N and González Arribas G and Miguélez Sanchez JR and García-Valle A and Ibañez M and Lozano Morillo F and García Manzanares Á and Sandoval-Moreno S and Cortes-Hernandez J and Palma Sanchez D and Lojo L and Cervantes Pérez EC and Collado P and Arciniega Larios C and Sala Icardo L and Labrador-Sánchez E and Peralta-Ginés C and Urionagüena Onaindia I and Plaza-Aulestia N and Medina Malone M and Gómez de Salazar JR and Corteguera M and Cebrián-Méndez L and Antón Pages FA and Lamua Riazuelo JR and Fábregas Canales MD and Alados Hernández MJ and Garijo Bufort M and Pàmies A and Sarabia de Ardanaz L and Aguirre-Del-Pino R and Cabezas Lefler JÁ and Seijas-Lopez Á and Carrasco Cubero MDC and López-Cerón Cofiño A and Ortiz-Santamaria V and Laiño Piñeiro M and Ordás Calvo C and Arconada Lopez C and Urruticoechea-Arana A and Garcia Magallon B and Acosta Alfaro AV and Leal Rodriguez S and Salido Olivares M and Lavilla Villar P and Brandy-García AM and Ros Vilamajo I and García Martos Á and Magallares Lopez BP and Sada Urmeneta G and Córdoba Martín C and Riera E and Bejerano C and Castañeda S and Blanco R},
year = {2026},
journal = {RMD open},
doi = {10.1136/rmdopen-2025-006549},
url = {https://doi.org/10.1136/rmdopen-2025-006549}
}RIS
TY - JOUR TI - Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review. AU - Calvo-Río V AU - Secada-Gómez C AU - Martín-Gutiérrez A AU - Retuerto-Guerrero M AU - Font J AU - Casafont-Solé I AU - Mayo-Juanatey A AU - Alegre Sancho JJ AU - Freites D AU - Hormigos C AU - Garrido Puñal N AU - González Arribas G AU - Miguélez Sanchez JR AU - García-Valle A AU - Ibañez M AU - Lozano Morillo F AU - García Manzanares Á AU - Sandoval-Moreno S AU - Cortes-Hernandez J AU - Palma Sanchez D AU - Lojo L AU - Cervantes Pérez EC AU - Collado P AU - Arciniega Larios C AU - Sala Icardo L AU - Labrador-Sánchez E AU - Peralta-Ginés C AU - Urionagüena Onaindia I AU - Plaza-Aulestia N AU - Medina Malone M AU - Gómez de Salazar JR AU - Corteguera M AU - Cebrián-Méndez L AU - Antón Pages FA AU - Lamua Riazuelo JR AU - Fábregas Canales MD AU - Alados Hernández MJ AU - Garijo Bufort M AU - Pàmies A AU - Sarabia de Ardanaz L AU - Aguirre-Del-Pino R AU - Cabezas Lefler JÁ AU - Seijas-Lopez Á AU - Carrasco Cubero MDC AU - López-Cerón Cofiño A AU - Ortiz-Santamaria V AU - Laiño Piñeiro M AU - Ordás Calvo C AU - Arconada Lopez C AU - Urruticoechea-Arana A AU - Garcia Magallon B AU - Acosta Alfaro AV AU - Leal Rodriguez S AU - Salido Olivares M AU - Lavilla Villar P AU - Brandy-García AM AU - Ros Vilamajo I AU - García Martos Á AU - Magallares Lopez BP AU - Sada Urmeneta G AU - Córdoba Martín C AU - Riera E AU - Bejerano C AU - Castañeda S AU - Blanco R PY - 2026 JO - RMD open DO - 10.1136/rmdopen-2025-006549 UR - https://doi.org/10.1136/rmdopen-2025-006549 ER -
APA
V, C., C, S., A, M., M, R., J, F., I, C., A, M., JJ, A. S., D, F., C, H., N, G. P., G, G. A., JR, M. S., A, G., M, I., F, L. M., Á, G. M., S, S., J, C., D, P. S., L, L., EC, C. P., P, C., C, A. L., L, S. I., E, L., C, P., I, U. O., N, P., M, M. M., JR, G. D. S., M, C., L, C., FA, A. P., JR, L. R., MD, F. C., MJ, A. H., M, G. B., A, P., L, S. D. A., R, A., JÁ, C. L., Á, S., MDC, C. C., A, L. C., V, O., M, L. P., C, O. C., C, A. L., A, U., B, G. M., AV, A. A., S, L. R., M, S. O., P, L. V., AM, B., I, R. V., Á, G. M., BP, M. L., G, S. U., C, C. M., E, R., C, B., S, C., & R, B. (2026). Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.. RMD open. https://doi.org/10.1136/rmdopen-2025-006549
Source records
- pubmed · retrieved 2026-09-26T00:32:35.032Z